Tag: Vaccination

Multivariant Covid Vaccine Booster Shows Promise, Early Data Suggests
Multivariant Covid Vaccine Booster Shows Promise, Early Data Suggests

The trials are being conducted by US-based biotechnology company Gritstone bio in collaboration with the University of Manchester and Manchester University NHS Foundation Trust.

  • Wednesday, 05 January 2022
Omicron Driving Covid Cases, Third Wave In India: Experts
Omicron Driving Covid Cases, Third Wave In India: Experts

India on Monday logged 33,750 new Covid-19 cases in a span of 24 hours, with an additional 123 fatalities, according to the Union Ministry of Health and Family Welfare. The rise in cases took the active caseload to 1,45,582, and pushed the nationwide death toll to 4,81,893.

  • Monday, 03 January 2022
Covid Scene In 2021: From Worse Than Better To Hope Of Vaccines
Covid Scene In 2021: From Worse Than Better To Hope Of Vaccines

As vaccination gradually picked up pace and its scope was expanded, the government battled controversies surrounding its supply and availability to states and union territories and modifying the vaccine purchase and distribution policies.

  • Wednesday, 29 December 2021
Global Covid Caseload Tops 281.3 Mn
Global Covid Caseload Tops 281.3 Mn

The other countries with over 5 million cases are the UK (12,277,814), Russia (10,236,301), Turkey (9,335,193), France (9,251,021), Germany (7,028,398), Iran (6,186,729), Spain (5,932,626), Italy (5,678,112), Argentina (5,480,305) and Colombia (5,127,971), the CSSE figures showed.

  • Tuesday, 28 December 2021
USA Reduces Covid-19 Isolation, Quarantine Time
US Reduces Covid-19 Isolation, Quarantine Time

The CDC has also updated its recommendation of quarantine period for those exposed to Covid-19. For people who are unvaccinated or are more than six months out from their second mRNA dose or more than 2 months after the Johnson & Johnson vaccine, and not yet boosted, CDC recommends quarantine for five days followed by strict mask use for an additional five days, Xinhua news agency reported.

  • Tuesday, 28 December 2021
Over 25 Lakh Children In Odisha To Get Covid Vaccine Doses From Jan 3 
Over 25 Lakh Children In Odisha To Get Covid Vaccine Doses From Jan 3 

Over 25 lakh eligible beneficiaries between 15-18 years age group in Odisha will start receiving doses from January 3.     

  • Monday, 27 December 2021
Kids 3 Times More At Risk Of Covid: Study
Kids 3 Times More At Risk Of Covid: Study

The study showed that the prevalence in children aged 12 to 17 years more than halved from 5.35 per cent to 2.31 per cent. As of December 14, 76.6 per cent children at ages 12 to 17 years had received at least one vaccine dose.

  • Thursday, 23 December 2021
Omicron Fight: Odisha Plans To Upscale Daily COVID Tests To 70K, Finish Vaccination By Jan 15
Omicron Fight: Odisha Plans To Upscale Daily COVID Tests To 70K, Cent Percent Vaccination By Jan 15

With rising scare of probable surge in the Corona infections driven by the newly discovered variant SARS-CoV-2 called Omicron, the Odisha government on Wednesday directed the district level authorities to enhance the daily Covid sample tests in the State to 70000.

  • Wednesday, 22 December 2021
India Currently Facing 3rd Covid Wave, To Hit Peak In February: Scientists
India Currently Facing 3rd Covid Wave, To Hit Peak In February: Scientists

A separate study led by a joint team from the IITs Hyderabad and Kanpur is based on the Sutra model, which tracks the country's Covid-19 trajectory.

  • Wednesday, 22 December 2021
Global Covid Caseload Tops 275.4 Mn
Global Covid Caseload Tops 275.4 Mn

The other countries with over 5 million cases are the UK (11,518,116), Russia (10,064,290), Turkey (9,191,851), France (8,745,272), Germany (6,834,488), Iran (6,173,369), Spain (5,535,231), Italy (5,405,360), Argentina (5,395,044) and Colombia (5,109,022), the CSSE figures showed.

  • Tuesday, 21 December 2021
Novavax Vax 90% Effective At Preventing Covid Infections
Novavax Vax 90% Effective At Preventing Covid Infections

Most side effects were mild to moderate and transient. Fever was very rare. The most common side effects in the vaccine recipients included pain and tenderness at the injection site, headache, muscle aches and fatigue that lasted a day on average. None of the recipients developed serious reactions like heart inflammation (myocarditis) or blood clots.

  • Friday, 17 December 2021
Omicron spreading fast across Europe, other parts of world; avoid non-essential travel: Govt
Omicron Spreading Fast Across Europe, Other Parts Of World; Avoid Non-Essential Travel: Govt

Giving details of Omicron cases in India, it said Maharashtra has reported 32 cases of the variant, Delhi (22), Rajasthan (17), Karnataka (8), Telangana (8), Gujarat (5), Kerala (5), Andhra Pradesh (1), Chandigarh (1), Tamil Nadu (1) and West Bengal (1), the government said.

  • Friday, 17 December 2021
'Booster Under Consideration, Priority On Both Doses Of Vaccines'
'Booster Under Consideration, Priority On Both Doses Of Vaccines'

Urging people to get vaccinated with second doses, Paul said the the increased Covid vaccine uptake is the need of the hour and urged people not to delay in getting fully vaccinated.

  • Thursday, 02 December 2021
Sputnik Light Vaccine To Be Launched In India By Dec
Sputnik Light Vaccine To Be Launched In India By Dec

The RDIF in the Webinar also announced the real-world data of the Ministry of Health of the Republic of San Marino on the Russian Sputnik V vaccine, demonstrating it is 80 per cent effective against coronavirus infection from 6 to 8 months after administering the second dose.

  • Wednesday, 24 November 2021
India Logs 10,302 Fresh Covid Infections, 267 More Deaths; Active Cases Decline To 1,24,8681
India Logs 10,302 Fresh Covid Infections, 267 More Deaths; Active Cases Decline To 1,24,8681

The daily positivity rate was recorded at 0.96 per cent. It has been less than 2 per cent for the last 47 days. The weekly positivity rate was 0.93 per cent. It has been below two per cent for the last 57 days.

  • Saturday, 20 November 2021
scrollToTop